Loading...
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Immune responses to SARS-CoV-2 might last for years, according to a study posted on the preprint server bioRxiv.
Some 185 adults who recovered from COVID-19 (most had mildly symptomatic disease) provided blood samples for analysis. The majority provided a single sample, but roughly 20% provided multiple samples over several months.
The researchers found that levels of spike-specific memory B cells (which make antibodies as needed) increased with time — and were higher at 4–6 months than at earlier time points in most participants who gave multiple samples. In addition, SARS-CoV-2 spike IgG titers were generally stable, showing only modest declines at 6–8 months.
One of the researchers told the New York Times, "That amount of [immune] memory would likely prevent the vast majority of people from getting hospitalized disease, severe disease, for many years."
Of note, a minority of participants in the study did not show long-lasting immune responses.
Comment
LINK(S):
Full study on bioRxiv (not peer-reviewed) (Free PDF)
New York Times story (Free)
NEJM Journal Watch COVID-19 page (Free)
NEJM COVID-19 page (Free)